Abstract:
Methods and devices create an intestinal braking effect, are non-invasive or minimally invasive, and may be reversible. These methods and devices are accomplished via stabilized implantable systems, and ingestible pills. In one embodiment, the implantable system comprises a device delivering a therapeutic substance to a target location within the gastrointestinal tract of a patient in order to initiate an intestinal braking effect which would promote sensations of satiety and stimulate excess weight loss for the patient.
Abstract:
An ultrasonic instrument comprises a body, a shaft assembly, an ultrasonic blade, and a pivoting member. The shaft assembly extends distally from the body. The ultrasonic blade is positioned distal to the shaft assembly. The pivoting member is pivotable with respect to the blade from an open position to a closed position to thereby clamp tissue between the pivoting member and the blade. The shaft assembly comprises a feature to provide for the removal of surgical debris (e.g. tissue, coagulated blood, etc.), body fluid, etc. from the shaft assembly. The feature may remove the surgical debris, body fluid, etc. from a cavity within the shaft assembly. The feature may also prevent the collection of surgical debris, body fluid, etc. within the shaft assembly.
Abstract:
An ultrasonic instrument comprises a body, a shaft assembly, an ultrasonic blade, and a pivoting member. The shaft assembly extends distally from the body. The ultrasonic blade is positioned distal to the shaft assembly. The pivoting member is pivotable with respect to the blade from an open position to a closed position to thereby clamp tissue between the pivoting member and the blade. The shaft assembly comprises a feature to provide for the removal of surgical debris (e.g. tissue, coagulated blood, etc.), body fluid, etc. from the shaft assembly. The feature may remove the surgical debris, body fluid, etc. from a cavity within the shaft assembly. The feature may also prevent the collection of surgical debris, body fluid, etc. within the shaft assembly.
Abstract:
An apparatus for stapling tissue includes a head assembly, a handle actuator in communication with the head assembly, and a staple cartridge. The head assembly is operable to drive a plurality of staples in response to actuating the handle actuator. The staple cartridge is in communication with the head assembly. The staple cartridge comprises a first annular ring of apertures and a second ring of apertures. The first annular ring of apertures includes apertures having a different size than the second annular ring of apertures, such that the apertures accommodate staples having different crown lengths. The staples may include pledgets that are configured to provide a greater staple footprint.
Abstract:
Methods and devices create an intestinal braking effect, are non-invasive or minimally invasive, and may be reversible. These methods and devices are accomplished via stabilized implantable systems, and ingestible pills. In one embodiment, the implantable system comprises a device delivering a therapeutic substance to a target location within the gastrointestinal tract of a patient in order to initiate an intestinal braking effect which would promote sensations of satiety and stimulate excess weight loss for the patient.
Abstract:
A surgical system comprises an end effector for operating on tissue and a screen positioned around the end effector. The screen is fluidly coupled with a suction source by a conduit such as a tube. The screen is configured to communicate suction through the screen while preventing tissue from contacting the end effector. The screen is further configured to retract proximally relative to the end effector to thereby expose the end effector.
Abstract:
A surgical system comprises an end effector for operating on tissue and a screen positioned around the end effector. The screen is fluidly coupled with a suction source by a conduit such as a tube. The screen is configured to communicate suction through the screen while preventing tissue from contacting the end effector. The screen is further configured to retract proximally relative to the end effector to thereby expose the end effector.